These effects, along with a past report demonstrating that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,two support the idea of targeting ACKR3 as a unique strategy to modulate the opioid procedure, which could open new therapeutic avenues for opioid-linked Conditions.The site is protected. The https:// makes sure